Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Progesterone - IBSA

Next Previous
Drug Profile

Progesterone - IBSA

Alternative Names: Inprosub; Lubion; Pleyris; Progedex; Progesterone-IBSA; Progiron; Prolutex

Latest Information Update: 09 Feb 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator IBSA
  • Developer Granata Bio; IBSA; Royan Institute
  • Class Hormonal contraceptives; Hormonal replacements; Infertility therapies; Pregnenediones; Small molecules
  • Mechanism of Action Glutamate antagonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Female infertility
  • Phase III Spontaneous abortion

Most Recent Events

  • 09 Feb 2026 Progesterone is still in phase III trial in Female infertility (In adults) in USA (SC) (NCT04549116)
  • 20 Oct 2022 Phase-III clinical trials in Female infertility (In adults) in USA (SC) before October 2022 (NCT04549116)
  • 12 Mar 2021 Phase III development for Female infertility is ongoing Italy (EudraCT2014-005474-11)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top